Cardinal Health buys Yong Yu from Zuellig

US pharmaceutical distributor Cardinal Health agrees to pay $470 million for China’s largest pharmaceutical importer, Zuellig Pharma China, known locally as Yong Yu.

Cardinal Health has paid $470 million to buy 100% of China’s largest pharmaceutical importer, Zuellig Pharma China, which is known locally as Yong Yu. The management team of Yong Yu will also join Cardinal.

Yong Yu is closely held and owned by Hong Kong-based Zuellig Pharma, which is part of the Zuellig Group. Zuellig Pharma was started by the Zuellig family 60 years ago in the Philippines and has grown into a business spread across 15 countries in Asia with a focus on distribution services for the healthcare industry. The group is now professionally managed and had a turnover of around $12 billion in 2009. In a press release announcing the deal, ...

¬ Haymarket Media Limited. All rights reserved.

FinanceAsia has updated its subscription model.

Registered readers now have the opportunity to read 5 articles from our award-winning website for free.

To obtain unlimited access to our award-winning exclusive news and analysis, we offer subscription packages, including single user, team subscription (2-5 users), or office-wide licences.

To help you and your colleagues access our proprietary content, please contact us at [email protected], or +(852) 2122 5222

Article limit is reached.

Hello! You have used up all of your free articles on FinanceAsia.

To obtain unlimited access to our award-winning exclusive news and analysis, we offer subscription packages, including single user, team subscription (2-5 users), or office-wide licences. To help you and your colleagues access our proprietary content, please contact us at [email protected], or +(852) 2122 5222